trial · primary record
VENT-03
Cutaneous Lupus Erythematosus (CLE)
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 24 |
| Primary completion | 2027-03 |
| Primary endpoint | Evaluate the effect of VENT-03 on the interferon gene signature in the skin |
| Registry ID | NCT07260877 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:43:31.063Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07260877
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.